TipRanks
Cardinal Health (CH:CLH)
:CLH
Switzerland Market

Cardinal Health (CLH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
14Ratings
Strong Buy
12 Buy
2 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

―
Based on 14 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is CHF223.63 with a high forecast of CHF241.86 and a low forecast of CHF207.07. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF241.86Average Price TargetCHF223.63Lowest Price TargetCHF207.07
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:CLH
Wells Fargo
Wells Fargo
CHF229.43
Buy
―
Reiterated
09/09/26
Wells Fargo Remains a Buy on Cardinal Health (CAH)
RBC Capital Analyst forecast on CH:CLH
RBC Capital
RBC Capital
CHF228.6
Buy
―
Initiated
08/19/26
Cardinal Health initiated with an Outperform at RBC CapitalCardinal Health initiated with an Outperform at RBC Capital
Barclays
CHF227.78
Buy
―
Reiterated
08/18/26
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Immatics (IMTX)
J.P. Morgan Analyst forecast on CH:CLH
J.P. Morgan
J.P. Morgan
CHF215.35
Hold
―
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (NASDAQ: SLN), Cardinal Health (NYSE: CAH) and Allogene Therapeutics (NASDAQ: ALLO)
Deutsche Bank  Analyst forecast on CH:CLH
Deutsche Bank
Deutsche Bank
CHF184.71→CHF216.18
Hold
―
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)
TD Cowen
CHF227.78→CHF231.92
Buy
―
Assigned
08/13/26
Analysts' Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)
Mizuho Securities Analyst forecast on CH:CLH
Mizuho Securities
Mizuho Securities
CHF198.79→CHF207.07
Buy
―
Reiterated
08/13/26
Analysts' Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)
Morgan Stanley Analyst forecast on CH:CLH
Morgan Stanley
Morgan Stanley
CHF219.49→CHF211.21
Buy
―
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
Evercore ISI
CHF223.63
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Citi
CHF219.49→CHF231.92
Buy
―
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on CH:CLH
Leerink Partners
Leerink Partners
CHF227.78→CHF241.86
Buy
―
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on CH:CLH
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Bank of America Securities Analyst forecast on CH:CLH
Bank of America Securities
Bank of America Securities
CHF215.35
Buy
―
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS
CHF215.35→CHF226.95
Buy
―
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:CLH
Wells Fargo
Wells Fargo
CHF229.43
Buy
―
Reiterated
09/09/26
Wells Fargo Remains a Buy on Cardinal Health (CAH)
RBC Capital Analyst forecast on CH:CLH
RBC Capital
RBC Capital
CHF228.6
Buy
―
Initiated
08/19/26
Cardinal Health initiated with an Outperform at RBC CapitalCardinal Health initiated with an Outperform at RBC Capital
Barclays
CHF227.78
Buy
―
Reiterated
08/18/26
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Immatics (IMTX)
J.P. Morgan Analyst forecast on CH:CLH
J.P. Morgan
J.P. Morgan
CHF215.35
Hold
―
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (NASDAQ: SLN), Cardinal Health (NYSE: CAH) and Allogene Therapeutics (NASDAQ: ALLO)
Deutsche Bank  Analyst forecast on CH:CLH
Deutsche Bank
Deutsche Bank
CHF184.71→CHF216.18
Hold
―
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)
TD Cowen
CHF227.78→CHF231.92
Buy
―
Assigned
08/13/26
Analysts' Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)
Mizuho Securities Analyst forecast on CH:CLH
Mizuho Securities
Mizuho Securities
CHF198.79→CHF207.07
Buy
―
Reiterated
08/13/26
Analysts' Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)
Morgan Stanley Analyst forecast on CH:CLH
Morgan Stanley
Morgan Stanley
CHF219.49→CHF211.21
Buy
―
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
Evercore ISI
CHF223.63
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Citi
CHF219.49→CHF231.92
Buy
―
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on CH:CLH
Leerink Partners
Leerink Partners
CHF227.78→CHF241.86
Buy
―
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on CH:CLH
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Bank of America Securities Analyst forecast on CH:CLH
Bank of America Securities
Bank of America Securities
CHF215.35
Buy
―
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS
CHF215.35→CHF226.95
Buy
―
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTVTvTv Therapeutics
MDWDMediwound
AXGNAxoGen
SIBNSI-Bone
LGNDLigand Pharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
Success Rate
10/13 ratings generated profit
77%
Average Return
+9.65%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +9.65% per trade.
1 Year
Success Rate
17/19 ratings generated profit
89%
Average Return
+28.51%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 89.47% of your transactions generating a profit, with an average return of +28.51% per trade.
2 Years
Eric ColdwellRobert W. Baird
Success Rate
25/27 ratings generated profit
93%
Average Return
+61.93%
Copying Eric Coldwell's trades and holding each position for 2 Years would result in 92.59% of your transactions generating a profit, with an average return of +61.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
13
14
16
20
19
Hold
1
1
1
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
17
24
23
In the current month, CLH has received 19 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 223.63.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is CHF2.42 with a range of CHF2.37 to CHF2.54. The previous quarter’s EPS was CHF2.39. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is CHF2.42 with a range of CHF2.37 to CHF2.54. The previous quarter’s EPS was CHF2.39. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is CHF54.89B with a range of CHF53.54B to CHF55.33B. The previous quarter’s sales results were CHF52.38B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is CHF54.89B with a range of CHF53.54B to CHF55.33B. The previous quarter’s sales results were CHF52.38B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is CH:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 223.63.
    What is CH:CLH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CLH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cardinal Health a Buy, Sell or Hold?
        Cardinal Health has a consensus rating of Strong Buy, which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Cardinal Health’s share price target?
          The average share price target for Cardinal Health is 223.63. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF241.86 ,and the lowest forecast is CHF207.07. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cardinal Health?
            Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
              How can I buy shares of Cardinal Health?
              To buy shares of CH:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.